Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013

TM’s 2nd World Immunology Online Conference

19 Mar 2013 - 21 Mar 2013 - Online

Bookmark and Share

Live Worldwide Discussion of these topics participate via your computer and internet connection Watch presentations live, ask questions by chat or phone 

March 19-21, 2013 9:00 AM EST (New York) / 3:00 PM CET (Europe)

FREE - Register for your seat today!!!

Researchers, Health Care Professionals, Patients,

Care Givers, All Interested People

60 live Presentations - ask your questions,

2 Symposiums - discussions on latest thoughts

Presentations also available to view at your schedule

Major symposiums of interest include, but not limited to Immunology, immunchemistry cancer and allergy, Biochemistry, Cell Biology, Immunology, Infectious Diseases, Molecular Biology

Topics will include
• Adaptive immunity
• Cytokine and cell adhesion
• Infection and immunity
• T/B cell immunity
• Antigen processing and presentation
• Immunity diseases molecular mechanisms
• Immune cell metabolism
• Immune regulation
• Leukocyte migration
• Immunotherapy
• Immunology of antibodies
• Antibody molecular targets
• Autoantibodies and autoimmunity
• Innate immunity and NK cells
• Macrophages, monocytes and dendritic cells

You will receive many benefits
• Follow major research developments in a variety of hot areas;
• Meet international speakers and attendees in real time;
• Network and exchange ideas with target audience;
• Build your solid reputation and impact;
• Establish more academic collaborations;
• All presentations and discussions are in real time;
• Eliminate travel, time, and money cost.

Highlights of the online conference
  • 60 oral presentations reflecting latest breakthroughs in field;
  • 12 major symposiums covering most areas of this field;
  • 12 Panel discussion sessions creating more networks;
  • All presentations and discussions are in real time;
  • Eliminate travel, time, and money cost.

 The cost is not hundreds or thousands of dollars plus travel expense.

Conference is FREE to attend. Register Today

Take a moment and register now at:

You'll receive reminder notices of presentations
You can participate live by logging in to watch, listen and ask questions during presentations, or you can view after on your schedule.

Other conferences scheduled - register NOW - FREE

Also - submit your papers.

3/19/2013  Immunotherapy Online Symposium 3/19/2013  Cellular Immunology Online Symposium
4/16/2013  HIV/AIDS Online Symposium 4/16/2013  Viruses & Infectious Disease Symposium
5/21/2013  Genome Instability & DNA Repair Symposium 5/21/2013  Microarray, Proteomics & Bioinformatics
6/18/2013  Brain Biology & Disease Symposium 6/18/2013  Pain Medicine Online Symposium
7/16/2013  Aging Online Symposium 8/15/2013  Pathology & Diagnosis Online Symposium
9/17/2013  Diabetes Online Symposium 9/17/2013  Nutrition & Obesity Online Symposium
9/17/2013  Heart Biology & Disease Symposium 9/17/2013  Blood & Blood Disorder Symposium
9/17/2013  Vascular Biology & Disease Symposium 10/15/2013  Drug Target/Deliver Online Symposium
10/15/2013  Vaccine Development Online Symposium 10/15/2013  Gene/Cell Therapy Online Symposium
10/15/2013  Clinical Trial Online Symposium 12/3/2013  Skin Biology & Disease Symposium
12/5/2013  Eye Biology & Disease Symposium 12/6/2013  Kidney Biology & Disease Symposium
12/7/2013  Bone Biology & Disease Symposium 12/8/2013  Gastrointestinal Biology & Disease Symposium
12/10/2013  Liver Biology & Disease Symposium 12/13/2013  Lung Biology & Disease Symposium
1/8/2014  Chemotherapy Online Symposium 1/8/2014  Breast Cancer Online Symposium
1/8/2014  Radiotherapy Online Symposium 2/5/2014  Animal Model Online Symposium
2/5/2014  Cell Signaling Pathway Symposium 2/5/2014  Protein Structure & Modification Symposium
2/5/2014  Stem & Progenitor Cell Symposium 2/5/2014  Cell Death Online Symposium
2/5/2014  GPCR Online Symposium Series 2/5/2014  RNA Biology Online Symposium

Conferences are FREE to attend.

                    Register Today

Take a moment and register now at:


Further information
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos